AI & Machine Learning

A new national reimbursement code for NeurAxis's IB-Stim therapy is set to revolutionize access for chronic GI pain patients, validating the technology.

A new partnership brings revolutionary 3D genome mapping from the lab to the clinic, offering new hope for patients with hard-to-treat cancers.

A new survey shows no firm recovers from cyberattacks in a day, with downtime lasting weeks. Yet, executive focus on resilience may be dangerously waning.

Sunwoda deepens its Sungrow alliance, unveiling advanced battery tech and a robust ESG strategy to lead the global clean energy transition.

After 30 years, CEO Jim Foster will retire, passing the torch to COO Birgit Girshick in a move that signals continuity and a new era of governance.

As household debt soars, Ramsey Solutions relaunches its EveryDollar app with AI tools and live coaching, aiming for a $20 billion annual impact.

Internet outages cost restaurants thousands. Bigleaf Networks' new 'Connected Kitchen' podcast explores how to build resilient networks and protect profits.

A new partnership aims to bring cutting-edge cancer trials to community clinics, accelerating drug development and expanding patient access to care.

Accenture's new investment in Profitmind's agentic AI platform signals a major shift for retail, promising to automate complex decisions and bridge the gap between data and action.

The new x-hoppers mobile app bridges the gap between the frontline and back office, creating a unified, AI-powered communication network for all staff.

With record growth and a fortified cash position, ElevateBio combines AI-driven discovery and industrial-scale manufacturing to power the gene therapy boom.

Keystone doubles down on AI advisory with Audax Private Equity's backing, spinning off its supply chain software unit into a new powerhouse, Keystone AI.

A new alliance between fintech innovators K1x and Juno promises to automate the most dreaded part of tax season, freeing CPAs from manual data entry.

A new vectorized antibody therapy for ALS, VTx-002, has been granted FDA Fast Track status, accelerating its path to patients battling the disease.

Otis secures a major TfL contract to upgrade 172 escalators, blending a century of history with future-ready tech for a smarter, more reliable commute.

A looming 10-million-ton copper deficit threatens to derail the AI revolution and the green energy transition, sparking a new era of geopolitical competition.

Replicate Bioscience secures major funding to develop next-gen self-replicating RNA vaccines, aiming for more durable and accessible global health solutions.

AI data platform Protege raises its Series A to $65M, tackling the critical data bottleneck with an ethical, licensing-first model for real-world data.

Eurythmics legend Dave Stewart launches a new venture builder to give artists control over their IP and revenue. But can this "creativity-first" model work?

Amid market headwinds, JD.com cancels $3B in shares to boost value, signaling deep confidence while juggling costly strategic growth initiatives.